Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Should we start screening for colon cancer at age 45?

Peter Ubel, MD
Conditions
February 17, 2019
Share
Tweet
Share

Here’s what most medical experts agree on: People 50 and older should be screened for colon cancer.

Here’s what is more controversial: Whether that screening should start, routinely, at age 45.

Recently, the American Cancer Society (ACS) recommended that colon cancer screenings start at age 45. Their recommendation was based in large part on an uptick in the number of people 45 to 50 years old who are being diagnosed with colon cancer in the last couple of decades, a 22% increase.

But the ACS recommendation might be recommending more cancer screening than the American public needs. In an op-ed in the Annals of Internal Medicine, three physicians raise important concerns about this new screening recommendation.

Why in heaven’s name would anyone raise questions about screening 45 year olds, in the face of this steep increase in cancer diagnoses? It boils down to three issues:

1. Exaggerated risk. While the 22% increase in cancer diagnoses is factually correct, it is also a relative risk increase, which makes the risk feel bigger than it really is. In actuality, the rate of cancer diagnoses in 45 to 50 year olds has risen from 5.9 to 7.2 people out of 100,000, an absolute increase of only 1.3%.

2. Unproven benefits. No randomized trials have proven that starting screening at age 45 saves lives. Instead, the ACS bases its recommendation on a computer model that predicts (but doesn’t establish) such benefit.

3. Lead time bias. If more people are being diagnosed with colon cancer at earlier ages, then you’d expect to see more people dying of cancer at those ages, too. But instead, death rates haven’t changed one bit. That stable death rate suggests that the increase in cancer diagnoses simply means we’re finding cancers that we would have found in time at a later point, even if we’d waited until age 50 to start screening. Here is a picture of this potential lead time bias, showing a line on top rising with that 1.3% increase in cancer diagnoses, and a flat line on the bottom showing no such change in cancer deaths:

Colorectal cancer incidence and mortality rates per 1,000 person-years and percentage of patients screened,

What’s the bottom line, so to speak?

  1. If you’re 50 or older, you should get screened for colon cancer.
  2. If you have an elevated risk of colon cancer – from family history, for example – ask your doctor if you should get screened before age 50. (You probably should.)
  3. If you’re at normal risk and wonder about getting screened at age 45, remember that starting at this age is unproven. We don’t really know, yet, whether screening tests will do you more good than harm.

Peter Ubel is a physician and behavioral scientist who blogs at his self-titled site, Peter Ubel and can be reached on Twitter @PeterUbel. He is the author of Critical Decisions: How You and Your Doctor Can Make the Right Medical Choices Together. This article originally appeared in Forbes.

Image credit: Shutterstock.com

Prev

When depersonalization is necessary in medicine

February 17, 2019 Kevin 12
…
Next

Physicians should stop being afraid of getting audited by the IRS

February 17, 2019 Kevin 5
…

ADVERTISEMENT

Tagged as: Gastroenterology, Oncology/Hematology

Post navigation

< Previous Post
When depersonalization is necessary in medicine
Next Post >
Physicians should stop being afraid of getting audited by the IRS

ADVERTISEMENT

More by Peter Ubel, MD

  • Clinicians shouldn’t be punished for taking care of needy populations

    Peter Ubel, MD
  • Patients alone cannot combat high health care prices

    Peter Ubel, MD
  • Is the FDA too slow to handle the pandemic?

    Peter Ubel, MD

Related Posts

  • When breast cancer screening guidelines conflict: Some patients face real consequences

    Leda Dederich
  • Rethinking consent in the age of Facebook and Cambridge Analytica

    Peter F. Nichol, MD, PhD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • Why physicians should start thinking about climate change

    Janice Boughton, MD
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Obstruction of medical justice: How health care fails patients with cancer

    Miriam A. Knoll, MD

More in Conditions

  • The patient carryover crisis: Why discharge education fails

    Rafiat Banwo, OTD
  • Why diagnostic error is high in offices

    Susan L. Montminy, EdD, MPA, RN and Marlene Icenhower, JD, RN
  • Medical statistics errors: How bad data hurts clinicians

    Gerald Kuo
  • Why food perfectionism harms parents

    Wendy Schofer, MD
  • Autism prevalence surveillance: a reckoning, not a crisis

    Ronald L. Lindsay, MD
  • Our relationship with medicine: a triumph

    Joseph Shaw
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The psychological trauma of polarization

      Farid Sabet-Sharghi, MD | Physician
  • Recent Posts

    • How medical gaslighting almost cost a neurologist her life [PODCAST]

      The Podcast by KevinMD | Podcast
    • Language doulas bridge care gaps

      Deepak Gupta, MD, Kaya Chakrabortty, and Yara Ismaeil | Physician
    • The patient carryover crisis: Why discharge education fails

      Rafiat Banwo, OTD | Conditions
    • Why diagnostic error is high in offices

      Susan L. Montminy, EdD, MPA, RN and Marlene Icenhower, JD, RN | Conditions
    • The myth of no frivolous medical lawsuits

      Howard Smith, MD | Physician
    • A pediatrician explains the real danger of food perfectionism [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The psychological trauma of polarization

      Farid Sabet-Sharghi, MD | Physician
  • Recent Posts

    • How medical gaslighting almost cost a neurologist her life [PODCAST]

      The Podcast by KevinMD | Podcast
    • Language doulas bridge care gaps

      Deepak Gupta, MD, Kaya Chakrabortty, and Yara Ismaeil | Physician
    • The patient carryover crisis: Why discharge education fails

      Rafiat Banwo, OTD | Conditions
    • Why diagnostic error is high in offices

      Susan L. Montminy, EdD, MPA, RN and Marlene Icenhower, JD, RN | Conditions
    • The myth of no frivolous medical lawsuits

      Howard Smith, MD | Physician
    • A pediatrician explains the real danger of food perfectionism [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Should we start screening for colon cancer at age 45?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...